
Abstract CT251: Immunological and histopathological tumor responses to a novel neoadjuvant peptide vaccine targeting HSP70 and GPC3 antigens in patients with resectable HCC
Author(s) -
Masahiro Nakajima,
Shoichi Hazama,
Koji Tamada,
Keiko Udaka,
Shun Doi,
Michiie Sakamoto,
Akira Saito,
Shiro Akinaga,
Hiroto Matsui,
Yoshitaro Shindo,
Satoshi Matsukuma,
Yukio Tokumitsu,
Shinobu Tomochika,
Michihisa Iida,
Shigeo Yoshida,
Ryouichi Tsunedomi,
Yuki Nakagami,
Nobuaki Suzuki,
Shigeru Takeda,
Hiroaki Nagano
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct251
Subject(s) - medicine , immunotherapy , cd8 , adjuvant , immune system , peptide vaccine , antigen , immunity , peripheral blood mononuclear cell , immunology , pathology , biology , epitope , in vitro , biochemistry